HK1066170A1 - 6-substitued pyrido-pyrimidines - Google Patents
6-substitued pyrido-pyrimidinesInfo
- Publication number
- HK1066170A1 HK1066170A1 HK04109141A HK04109141A HK1066170A1 HK 1066170 A1 HK1066170 A1 HK 1066170A1 HK 04109141 A HK04109141 A HK 04109141A HK 04109141 A HK04109141 A HK 04109141A HK 1066170 A1 HK1066170 A1 HK 1066170A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- substitued
- pyrido
- pyrimidines
- substitued pyrido
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26837501P | 2001-02-12 | 2001-02-12 | |
US33465401P | 2001-11-30 | 2001-11-30 | |
PCT/EP2002/001106 WO2002064594A2 (fr) | 2001-02-12 | 2002-02-04 | Pyrido-pyrimidines substituees en position 6 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1066170A1 true HK1066170A1 (en) | 2005-03-18 |
Family
ID=26953040
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK04109141A HK1066170A1 (en) | 2001-02-12 | 2004-11-19 | 6-substitued pyrido-pyrimidines |
Country Status (32)
Country | Link |
---|---|
US (3) | US6696566B2 (fr) |
EP (1) | EP1361880B1 (fr) |
JP (1) | JP4064818B2 (fr) |
KR (1) | KR100639772B1 (fr) |
CN (1) | CN100376571C (fr) |
AR (1) | AR035854A1 (fr) |
AT (1) | ATE305303T1 (fr) |
AU (1) | AU2002256615B2 (fr) |
BR (1) | BRPI0207172B8 (fr) |
CA (1) | CA2434834C (fr) |
CZ (1) | CZ20032416A3 (fr) |
DE (1) | DE60206363T2 (fr) |
DK (1) | DK1361880T3 (fr) |
ES (1) | ES2249574T3 (fr) |
HK (1) | HK1066170A1 (fr) |
HR (1) | HRP20030624B1 (fr) |
HU (1) | HU229604B1 (fr) |
IL (2) | IL156872A0 (fr) |
JO (1) | JO2410B1 (fr) |
MA (1) | MA26993A1 (fr) |
MX (1) | MXPA03007166A (fr) |
MY (1) | MY131518A (fr) |
NO (1) | NO326133B1 (fr) |
NZ (1) | NZ526961A (fr) |
PA (1) | PA8539201A1 (fr) |
PE (1) | PE20020976A1 (fr) |
PL (1) | PL366918A1 (fr) |
RU (1) | RU2269527C2 (fr) |
SK (1) | SK11322003A3 (fr) |
WO (1) | WO2002064594A2 (fr) |
YU (1) | YU63703A (fr) |
ZA (1) | ZA200305938B (fr) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7053070B2 (en) * | 2000-01-25 | 2006-05-30 | Warner-Lambert Company | Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors |
CA2434834C (fr) | 2001-02-12 | 2010-09-14 | F. Hoffmann-La Roche Ag | Pyrido-pyrimidines substituees en position 6 |
DK1470124T3 (da) * | 2002-01-22 | 2006-04-18 | Warner Lambert Co | 2-(Pyridin-2-yl amino)-pyrido[2,3]pyrimidin-7-oner |
AU2003215675B2 (en) | 2002-04-03 | 2007-07-12 | F. Hoffmann-La Roche Ag | Imidazo fused compounds |
RU2324695C2 (ru) * | 2002-08-06 | 2008-05-20 | Ф.Хоффманн-Ля Рош Аг | 6-АЛКОКСИПИРИДОПИРИМИДИНЫ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ОБЛАДАЮЩАЯ АКТИВНОСТЬЮ ИНГИБИТОРОВ КИНАЗЫ МАР р38 |
DE60331367D1 (de) | 2002-12-30 | 2010-04-01 | Angiotech Int Ag | Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung |
PT2476667E (pt) * | 2003-02-26 | 2014-09-18 | Sugen Inc | Compostos de aminoheteroarilo como inibidores da proteína quinase |
CN1774250A (zh) * | 2003-04-16 | 2006-05-17 | 霍夫曼-拉罗奇有限公司 | 作为治疗诸如类风湿性关节炎的炎性疾病的p38激酶抑制剂的(6-(苯氧基)-吡啶并[3,4-d]嘧啶-2-基)-胺衍生物 |
EP1685131B1 (fr) * | 2003-11-13 | 2007-03-07 | F. Hoffmann-La Roche AG | Pyrido-7-pyrimidin-7-ones substitues hydroxyalkyle |
EP1831215A1 (fr) * | 2004-11-23 | 2007-09-12 | Ranbaxy Laboratories Limited | Pyrido[2, 3-d]pyrimidines utilisees comme agents anti-inflammatoires |
US20060142312A1 (en) * | 2004-12-23 | 2006-06-29 | Pfizer Inc | C6-aryl and heteroaryl substituted pyrido[2,3-D] pyrimidin-7-ones |
US20090036472A1 (en) * | 2005-02-02 | 2009-02-05 | Palle Venkata P | Azabicyclo derivatives as anti-inflammatory agents |
WO2006119504A2 (fr) * | 2005-05-04 | 2006-11-09 | Renovis, Inc. | Composes heterocycliques fusionnes, leurs compositions et leurs utilisations |
DE602006010564D1 (de) * | 2005-07-21 | 2009-12-31 | Hoffmann La Roche | Pyridoä2,3-düpyrimidin-2,4-diamin-verbindungen als ptpib-hemmer |
PL2099797T3 (pl) * | 2005-08-09 | 2011-03-31 | Irm Llc | Związki i kompozycje jako inhibitory kinaz białkowych |
US8686002B2 (en) | 2005-08-21 | 2014-04-01 | AbbVie Deutschland GmbH & Co. KG | Heterocyclic compounds and their use as binding partners for 5-HT5 receptors |
JO2783B1 (en) * | 2005-09-30 | 2014-03-15 | نوفارتيس ايه جي | Compounds 2-Amino-7, 8-dihydro-6H-Bayredo (3,4-D) Pyrimidine-5-Ones |
WO2008150260A1 (fr) * | 2007-06-06 | 2008-12-11 | Gpc Biotech, Inc. | Inhibiteurs de kinase |
WO2008078249A1 (fr) * | 2006-12-21 | 2008-07-03 | Ranbaxy Laboratories Limited | Agents anti-inflammatoires |
AU2008248296B2 (en) | 2007-05-07 | 2011-12-01 | Amgen Inc. | Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators, process for their preparation, and their pharmaceutical use |
CN101679211A (zh) | 2007-06-15 | 2010-03-24 | 霍夫曼-拉罗奇有限公司 | 用于制备3-氨基-戊-1,5-二醇的新方法 |
WO2009117156A1 (fr) | 2008-03-21 | 2009-09-24 | Amgen Inc. | Composés de pyrazolo-pyrazinones et leurs procédés d’utilisation |
EP2112150B1 (fr) | 2008-04-22 | 2013-10-16 | Forma Therapeutics, Inc. | Inhibiteurs Raf améliorés |
WO2010046273A2 (fr) * | 2008-10-22 | 2010-04-29 | F. Hoffmann-La Roche Ag | Inhibiteurs pyrimidinylpyridone de jnk |
US8674095B2 (en) | 2008-12-19 | 2014-03-18 | Afraxis Holdings, Inc. | Compounds for treating neuropsychiatric conditions |
WO2011044535A2 (fr) | 2009-10-09 | 2011-04-14 | Afraxis, Inc. | 8-ethyl-6-(aryl)pyrido[2,3-d]pyrimidin-7(8h)-ones pour le traitement de troubles de snc |
WO2011075616A1 (fr) | 2009-12-18 | 2011-06-23 | Temple University - Of The Commonwealth System Of Higher Education | Pyrido[2,3-d]pyrimidin-7(8h)-ones substitués et leurs utilisations thérapeuthiques |
EP3172214B1 (fr) | 2014-07-26 | 2020-05-13 | Sunshine Lake Pharma Co., Ltd. | 2-amino-pyrido [2,3-d]pyrimidin -7 (8h)-one utilisés en tant qu'inhibiteurs de cdk et utilisations de ceux-ci |
UA123914C2 (uk) | 2016-06-08 | 2021-06-23 | Суппорт-Венче Гмбх | Фармацевтичні комбінації для лікування раку |
UA124804C2 (uk) | 2016-08-15 | 2021-11-24 | Пфайзер Інк. | Піридопіримідинонові інгібітори cdk2/4/6 |
AU2017313296A1 (en) * | 2016-08-17 | 2019-02-14 | Support-Venture Gmbh | Method of preventing or treating hearing loss |
WO2018132550A1 (fr) | 2017-01-11 | 2018-07-19 | The General Hospital Corporation | Agents d'imagerie à canaux sodiques dépendant de la tension |
AU2018248578A1 (en) | 2017-04-04 | 2019-10-17 | Kinarus Ag | Methods of preventing or treating ophthalmic diseases |
JP2021501123A (ja) * | 2017-08-31 | 2021-01-14 | デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド | Egfrおよび/またはher2の阻害剤ならびに使用方法 |
US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
NZ762856A (en) | 2017-10-05 | 2020-07-31 | Fulcrum Therapeutics Inc | P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd |
US20210261547A1 (en) * | 2018-06-27 | 2021-08-26 | Tufts Medical Center, Inc. | Pyridopyrimidine compounds and methods of their use |
AU2019300135A1 (en) | 2018-07-13 | 2021-01-28 | Kinarus Ag | Combinations of PPAR agonists and p38 kinase inhibitors for preventing or treating fibrotic diseases |
TW202112368A (zh) | 2019-06-13 | 2021-04-01 | 荷蘭商法西歐知識產權股份有限公司 | 用於治療有關dux4表現之疾病的抑制劑組合 |
US20230263803A1 (en) | 2020-08-11 | 2023-08-24 | Kinarus Ag | Methods of preventing or treating covid-19 and related viral diseases or disorders |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4215216A (en) | 1979-04-18 | 1980-07-29 | American Home Products Corporation | 7,8-Dihydro-2,5,8-trisubstituted-7-oxo-pyrido[2,3-d]pyrimidine-6-carboxylic acid derivatives |
US5037826A (en) | 1986-10-15 | 1991-08-06 | Schering Corporation | 1-substituted naphthyridine and pyridopyrazine derivatives |
GB8702758D0 (en) * | 1987-02-06 | 1987-03-11 | Wellcome Found | Treatment of disease |
AU598093B2 (en) | 1987-02-07 | 1990-06-14 | Wellcome Foundation Limited, The | Pyridopyrimidines, methods for their preparation and pharmaceutical formulations thereof |
WO1993017682A1 (fr) | 1992-03-04 | 1993-09-16 | Abbott Laboratories | Antagonistes des recepteurs de l'angiotensine ii |
IL115256A0 (en) | 1994-11-14 | 1995-12-31 | Warner Lambert Co | 6-Aryl pyrido (2,3-d) pyrimidines and naphthyridines and their use |
ES2146782T3 (es) | 1994-11-14 | 2000-08-16 | Warner Lambert Co | 6-aril-pirido(2,3-d)pirimidinas y naftiridinas para la inhibicion de la proliferacion celular inducida por la proteina tirosina quinasa. |
US5620981A (en) | 1995-05-03 | 1997-04-15 | Warner-Lambert Company | Pyrido [2,3-D]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation |
IL117923A (en) | 1995-05-03 | 2000-06-01 | Warner Lambert Co | Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds |
AR004010A1 (es) | 1995-10-11 | 1998-09-30 | Glaxo Group Ltd | Compuestos heterociclicos |
US6107300A (en) | 1996-03-27 | 2000-08-22 | Dupont Pharmaceuticals | Arylamino fused pyrimidines |
US6147080A (en) * | 1996-12-18 | 2000-11-14 | Vertex Pharmaceuticals Incorporated | Inhibitors of p38 |
EP0964864B1 (fr) | 1997-02-05 | 2008-04-09 | Warner-Lambert Company LLC | Pyrido 2,3d pyrimidines et 4-aminopyrimidines en tant qu'inhibiteurs de la proliferation cellulaire |
US5945422A (en) | 1997-02-05 | 1999-08-31 | Warner-Lambert Company | N-oxides of amino containing pyrido 2,3-D! pyrimidines |
TW458977B (en) * | 1997-04-16 | 2001-10-11 | Abbott Lab | 6,7-disubstituted-4-aminopyrido[2,3-D] pyrimidine compounds |
AU7108398A (en) | 1997-04-16 | 1998-11-11 | Abbott Laboratories | 5,7-disubstituted 4-aminopyrido{2,3-d}pyrimidine compounds and their use as adenosine kinase inhibitors |
CN1252069A (zh) | 1997-04-16 | 2000-05-03 | 艾博特公司 | 5,6,7-三取代的-4-氨基吡啶并[2,3-d]嘧啶化合物 |
PL344248A1 (en) | 1998-05-26 | 2001-10-22 | Warner Lambert Co | Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
AU3951899A (en) | 1998-06-19 | 2000-01-05 | Pfizer Products Inc. | Pyrrolo(2,3-d)pyrimidine compounds |
ES2258431T3 (es) | 1999-08-02 | 2006-09-01 | F. Hoffmann-La Roche Ag | Proceso para la preparacion de derivados de benzotiofeno. |
US7053070B2 (en) * | 2000-01-25 | 2006-05-30 | Warner-Lambert Company | Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors |
MXPA02008535A (es) * | 2000-03-06 | 2002-12-13 | Warner Lambert Co | Inhibidores de 5-alquilpirido (2.3-d) pirimidinas tirosina quinasa. |
US6518276B2 (en) * | 2000-08-31 | 2003-02-11 | Syntex (U.S.A.) Llc | 7-oxo-pyridopyrimidines (II) |
CA2434834C (fr) | 2001-02-12 | 2010-09-14 | F. Hoffmann-La Roche Ag | Pyrido-pyrimidines substituees en position 6 |
DK1470124T3 (da) * | 2002-01-22 | 2006-04-18 | Warner Lambert Co | 2-(Pyridin-2-yl amino)-pyrido[2,3]pyrimidin-7-oner |
-
2002
- 2002-02-04 CA CA2434834A patent/CA2434834C/fr not_active Expired - Lifetime
- 2002-02-04 CZ CZ20032416A patent/CZ20032416A3/cs unknown
- 2002-02-04 DE DE60206363T patent/DE60206363T2/de not_active Expired - Lifetime
- 2002-02-04 DK DK02726103T patent/DK1361880T3/da active
- 2002-02-04 YU YU63703A patent/YU63703A/sh unknown
- 2002-02-04 NZ NZ526961A patent/NZ526961A/en unknown
- 2002-02-04 CN CNB028048342A patent/CN100376571C/zh not_active Expired - Lifetime
- 2002-02-04 MX MXPA03007166A patent/MXPA03007166A/es active IP Right Grant
- 2002-02-04 KR KR1020037010562A patent/KR100639772B1/ko active IP Right Grant
- 2002-02-04 SK SK11322003A patent/SK11322003A3/sk unknown
- 2002-02-04 AT AT02726103T patent/ATE305303T1/de active
- 2002-02-04 JP JP2002564525A patent/JP4064818B2/ja not_active Expired - Lifetime
- 2002-02-04 HU HU0303458A patent/HU229604B1/hu unknown
- 2002-02-04 PL PL02366918A patent/PL366918A1/xx not_active Application Discontinuation
- 2002-02-04 AU AU2002256615A patent/AU2002256615B2/en not_active Expired
- 2002-02-04 ES ES02726103T patent/ES2249574T3/es not_active Expired - Lifetime
- 2002-02-04 IL IL15687202A patent/IL156872A0/xx unknown
- 2002-02-04 EP EP02726103A patent/EP1361880B1/fr not_active Expired - Lifetime
- 2002-02-04 BR BR0207172-0 patent/BRPI0207172B8/pt not_active IP Right Cessation
- 2002-02-04 WO PCT/EP2002/001106 patent/WO2002064594A2/fr not_active Application Discontinuation
- 2002-02-04 RU RU2003125887/04A patent/RU2269527C2/ru not_active IP Right Cessation
- 2002-02-06 JO JO200212A patent/JO2410B1/en active
- 2002-02-08 PA PA20028539201A patent/PA8539201A1/es unknown
- 2002-02-08 PE PE2002000097A patent/PE20020976A1/es not_active Application Discontinuation
- 2002-02-11 MY MYPI20020491A patent/MY131518A/en unknown
- 2002-02-11 US US10/073,845 patent/US6696566B2/en not_active Expired - Lifetime
- 2002-02-11 AR ARP020100430A patent/AR035854A1/es unknown
-
2003
- 2003-07-10 IL IL156872A patent/IL156872A/en unknown
- 2003-07-31 ZA ZA2003/05938A patent/ZA200305938B/en unknown
- 2003-08-01 HR HR20030624A patent/HRP20030624B1/xx not_active IP Right Cessation
- 2003-08-11 NO NO20033540A patent/NO326133B1/no not_active IP Right Cessation
- 2003-08-11 MA MA27273A patent/MA26993A1/fr unknown
- 2003-11-25 US US10/722,703 patent/US7169794B2/en not_active Expired - Lifetime
-
2004
- 2004-11-19 HK HK04109141A patent/HK1066170A1/xx not_active IP Right Cessation
-
2007
- 2007-01-09 US US11/651,302 patent/US7449581B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60217162D1 (en) | Tetrafluorethen-perfluorbutylethen-copolymer | |
DE60209787D1 (en) | Flächiges implantat | |
DE50202400D1 (en) | Baw-resonator | |
DE50201180D1 (en) | Organopolysiloxan/polyharnstoff/polyurethan-blockcopolymere | |
DE60213216D1 (en) | Metalloproteinaseinhibitoren | |
DE50209614D1 (en) | 2-heteroarylcarbonsäureamide | |
DE60217478D1 (en) | Sychrongleichrichter | |
DE50211022D1 (en) | Heteroarylcarbonsäureamide | |
HK1066170A1 (en) | 6-substitued pyrido-pyrimidines | |
DE60214551D1 (en) | Modulares airbagaufblassystem | |
DE60210819D1 (en) | Pyrazolopyridazinderivate | |
DE60141364D1 (en) | Polyphenylensulfidharzzusammensetzung | |
DE60141362D1 (en) | Ösophagus-stoma-knopf | |
DE50202633D1 (en) | Ophthalmoskop | |
AU2002360430A8 (en) | 14-methyl-epothilones | |
DE60107296D1 (en) | Kabelverstärkerverbindungsanordnung | |
DE60204140D1 (en) | 5-ethyl-imidazotriazinone | |
DE60216319D1 (en) | Heteroaryl-substituierte aminocyclohexan-derivate | |
DE50206483D1 (en) | Displaymodul | |
DE50203686D1 (en) | Substituierte c-furan-2-yl-methylamin- und c-thiophen-2-yl-methylamin-derivate | |
DE50201028D1 (en) | Diarylgelbpigmentpraeparationen | |
DE50214962D1 (en) | Heterocyclylarylsulfonamide | |
DE60206072D1 (en) | Aroylpyridinone | |
AU2002313943A8 (en) | Electromobile | |
AU2001100134A4 (en) | Enviro-trap |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20120204 |